# Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/association-of-sglt2-inhibitors-with-cardiovascular-kidney-and-safety-outcomes/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Arnaud D. Kazé,Min Zhuo,Seoyoung C. Kim,Elisabetta Patorno,Julie M. Paik |
| Citations | 157 |
| DOI | 10.1186/s12933-022-01476-x |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-022-01476-x |
| OpenAlex ID | https://openalex.org/W4220750929 |
| PMID | 35321742 |
| Type | review |
| Year | 2022 |

## Paper authors

- [Min Zhuo](https://scholariq.org/researchers/min-zhuo/)

## Paper journal

- [Cardiovascular Diabetology](https://scholariq.org/journals/cardiovascular-diabetology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.